BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 3116996)

  • 21. Use of labetalol in the treatment of severe hypertension during pregnancy.
    Michael CA
    Br J Clin Pharmacol; 1979; 8(Suppl 2):211S-215S. PubMed ID: 526403
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Labetalol vs. methyldopa in the treatment of pregnancy-induced hypertension.
    el-Qarmalawi AM; Morsy AH; al-Fadly A; Obeid A; Hashem M
    Int J Gynaecol Obstet; 1995 May; 49(2):125-30. PubMed ID: 7649315
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fetal haemodynamics before and after treatment of maternal hypertension in pregnancy.
    Rasmussen K
    Dan Med Bull; 1987 Jun; 34(3):170-2. PubMed ID: 3595214
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drugs in pregnancy. Antihypertensives.
    Magee LA
    Best Pract Res Clin Obstet Gynaecol; 2001 Dec; 15(6):827-45. PubMed ID: 11800527
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral antihypertensive regimens (nifedipine retard, labetalol, and methyldopa) for management of severe hypertension in pregnancy: an open-label, randomised controlled trial.
    Easterling T; Mundle S; Bracken H; Parvekar S; Mool S; Magee LA; von Dadelszen P; Shochet T; Winikoff B
    Lancet; 2019 Sep; 394(10203):1011-1021. PubMed ID: 31378394
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparison of labetalol plus hospitalization versus hospitalization alone in the management of preeclampsia remote from term.
    Sibai BM; Gonzalez AR; Mabie WC; Moretti M
    Obstet Gynecol; 1987 Sep; 70(3 Pt 1):323-7. PubMed ID: 3627579
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methyldopa versus labetalol or no medication for treatment of mild and moderate chronic hypertension during pregnancy: a randomized clinical trial.
    Rezk M; Emarh M; Masood A; Dawood R; El-Shamy E; Gamal A; Badr H
    Hypertens Pregnancy; 2020 Nov; 39(4):393-398. PubMed ID: 32697618
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Basic and metabolic therapy of hypertensive disease in pregnant women].
    Leshchinskiĭ LA; Gaĭsin IR; Maksimov NI
    Klin Med (Mosk); 2008; 86(9):25-8. PubMed ID: 19048832
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of maternal labetalol on the newborn infant.
    Munshi UK; Deorari AK; Paul VK; Singh M
    Indian Pediatr; 1992 Dec; 29(12):1507-12. PubMed ID: 1291496
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trends in using beta-blockers and methyldopa for hypertensive disorders during pregnancy in a Canadian population.
    Xie RH; Guo Y; Krewski D; Mattison D; Nerenberg K; Walker MC; Wen SW
    Eur J Obstet Gynecol Reprod Biol; 2013 Dec; 171(2):281-5. PubMed ID: 24139131
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Treatment of hypertensive diseases in pregnancy--general recommendations and long-term oral therapy].
    Rath W
    Z Geburtshilfe Neonatol; 1997; 201(6):240-6. PubMed ID: 9491543
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The short term effects of oral labetalol in patients with chronic renal disease and hypertension.
    Innes A; Gemmell HG; Smith FW; Edward N; Catto GR
    J Hum Hypertens; 1992 Jun; 6(3):211-4. PubMed ID: 1629891
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A randomized trial of tight vs. less tight control of mild essential and gestational hypertension in pregnancy.
    El Guindy AA; Nabhan AF
    J Perinat Med; 2008; 36(5):413-8. PubMed ID: 18605968
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The fetal outcome in a randomized double-blind controlled trial of labetalol versus placebo in pregnancy-induced hypertension.
    Pickles CJ; Symonds EM; Broughton Pipkin F
    Br J Obstet Gynaecol; 1989 Jan; 96(1):38-43. PubMed ID: 2647130
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association between labetalol use for hypertension in pregnancy and adverse infant outcomes.
    Xie RH; Guo Y; Krewski D; Mattison D; Walker MC; Nerenberg K; Wen SW
    Eur J Obstet Gynecol Reprod Biol; 2014 Apr; 175():124-8. PubMed ID: 24502872
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Use of alphamethyldopa during the pregnancy-puerperium cycle in hypertensive patients and evaluation of their offspring up to their 3rd year of life].
    De Andrade J
    Arq Bras Cardiol; 1990 Aug; 55(2):137-9. PubMed ID: 2073176
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of labetalol and dihydralazine in hypertensive emergencies of pregnancy.
    Ashe RG; Moodley J; Richards AM; Philpott RH
    S Afr Med J; 1987 Mar; 71(6):354-6. PubMed ID: 3551127
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduced prevalence of early preterm delivery in women with Type 1 diabetes and microalbuminuria--possible effect of early antihypertensive treatment during pregnancy.
    Nielsen LR; Müller C; Damm P; Mathiesen ER
    Diabet Med; 2006 Apr; 23(4):426-31. PubMed ID: 16620272
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management of the pregnant patient with chronic hypertension.
    Hayashi RH
    Clin Ther; 1983; 5(6):568-78. PubMed ID: 6138151
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral nifedipine versus intravenous labetalol for acute blood pressure control in hypertensive emergencies of pregnancy: a randomised trial.
    Raheem IA; Saaid R; Omar SZ; Tan PC
    BJOG; 2012 Jan; 119(1):78-85. PubMed ID: 21985500
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.